
Commentary|Articles|September 16, 2026
Four years, 500 cases: The case for office-based retina surgery
Author(s)Jonathan Feistmann, MD
Fact checked by: Kassi Filkins
After four years and 500+ office-based procedures, Johnathan Feistmann, MD, shares how the model shortened time to surgery for fovea-threatening cases while reshaping patient experience and practice workflow.
Advertisement
Advertisement
For decades, vitreoretinal surgery has been closely tied to hospitals and ambulatory surgery centers (ASCs), where access to operating rooms, anesthesia services, and specialized equipment dictated when—and often how quickly—patients could receive care. Today, however, limited retinal OR access—especially for urgent and after-hours cases—along with advances in surgical technology and anesthesia techniques are prompting some of us to rethink that longstanding mode.
Related to this article

Prevent Blindness marks IED Week, October 19 to 25, as new therapies and pivotal trials reshape care for uveitis and thyroid eye disease.

Noab Banoub, a third year medical student, describes his journey into medicine and his view of ophthalmology's future.

Arun C. Gulani, MD, applies his keratoconus classification to cross-linking, rings, transplant, lens surgery, and staged care.

Patients with atrial fibrillation (AF) had measurable structural retinal changes in a large international study.

Rheumatoid arthritis, is an autoimmune disorder, develops more often in women than men in a 3:1 ratio.

IRIS Registry data showed no change in anti-VEGF frequency, vision, or retinal thickness after patients with DME began a GLP-1RA.

In the latest episode of The Retina TL;DR with Dr. Weng—Part 2 of a special two-part series—host Christina Y. Weng, MD, MBA, FASRS, sits down with two more of her former residents for candid advice on transitioning into fellowship, balancing research and family, and what excites them most about the future of retina.
Advertisement
Advertisement

